Variant report
Variant | esv18391 |
---|---|
Chromosome Location | chr6:11477421-11483532 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr6:11478253-11478453 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | EP300 | chr6:11479344-11480001 | ECC-1 | luminal epithelium: | n/a | n/a |
3 | ESR1 | chr6:11479464-11479865 | ECC-1 | luminal epithelium: | n/a | n/a |
4 | ESR1 | chr6:11479462-11479859 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | ESR1 | chr6:11479533-11479895 | ECC-1 | luminal epithelium: | n/a | n/a |
6 | ESR1 | chr6:11479385-11479881 | ECC-1 | luminal epithelium: | n/a | n/a |
7 | ESR1 | chr6:11479394-11479881 | ECC-1 | luminal epithelium: | n/a | n/a |
8 | TEAD4 | chr6:11479389-11479946 | ECC-1 | luminal epithelium: | n/a | n/a |
9 | ZNF263 | chr6:11478803-11479212 | HEK293-T-REx | kidney: | n/a | chr6:11478986-11479007 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000242753 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6904209 | chr6:11477428-11477429 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs563881440 | chr6:11477471-11477472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142764972 | chr6:11477486-11477487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74848988 | chr6:11477487-11477488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6904400 | chr6:11477493-11477494 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs562792176 | chr6:11477502-11477503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185329195 | chr6:11477512-11477513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538553821 | chr6:11477526-11477527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371210175 | chr6:11477534-11477535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531764604 | chr6:11477552-11477553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9357150 | chr6:11477585-11477586 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs145024924 | chr6:11477611-11477612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377559147 | chr6:11477718-11477719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553816772 | chr6:11477746-11477747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138808048 | chr6:11477753-11477754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142075079 | chr6:11477788-11477789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562948034 | chr6:11477820-11477821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368292184 | chr6:11477868-11477869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146326234 | chr6:11477903-11477904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564085756 | chr6:11477920-11477921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532990844 | chr6:11477932-11477933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546633779 | chr6:11477933-11477934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566544735 | chr6:11477947-11477948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529000185 | chr6:11477958-11477959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190134873 | chr6:11478070-11478071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536222234 | chr6:11478190-11478191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566942105 | chr6:11478192-11478193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181330306 | chr6:11478208-11478209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532237674 | chr6:11478307-11478308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533907981 | chr6:11478308-11478309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538468907 | chr6:11478319-11478320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553755410 | chr6:11478343-11478344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113133639 | chr6:11478390-11478391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552305857 | chr6:11478414-11478415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9461774 | chr6:11478434-11478435 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs186477733 | chr6:11478450-11478451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370711195 | chr6:11478459-11478460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556711659 | chr6:11478461-11478462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191827907 | chr6:11478474-11478475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545667151 | chr6:11478534-11478535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9380311 | chr6:11478536-11478537 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs7748276 | chr6:11478575-11478576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540188733 | chr6:11478609-11478610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183595767 | chr6:11478637-11478638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528995747 | chr6:11478652-11478653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548834758 | chr6:11478706-11478707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562688804 | chr6:11478731-11478732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10456408 | chr6:11478736-11478737 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs574081688 | chr6:11478740-11478741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139369755 | chr6:11478749-11478750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20688739 | CNVD |
Cancer | 21183584 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:11470200-11479200 | Weak transcription | Fetal Kidney | kidney |
2 | chr6:11475000-11480600 | Weak transcription | Placenta | Placenta |
3 | chr6:11478600-11479000 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr6:11478800-11480600 | Weak transcription | Ovary | ovary |
5 | chr6:11479200-11480200 | Enhancers | Fetal Kidney | kidney |
6 | chr6:11480200-11491200 | Weak transcription | Fetal Kidney | kidney |
7 | chr6:11480600-11480800 | Enhancers | Pancreas | Pancrea |
8 | chr6:11480600-11481000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
9 | chr6:11480600-11481200 | Enhancers | Ovary | ovary |
10 | chr6:11481000-11483600 | Weak transcription | Pancreas | Pancrea |
11 | chr6:11481000-11486600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
12 | chr6:11481200-11485800 | Weak transcription | Ovary | ovary |
13 | chr6:11482800-11483000 | Enhancers | Fetal Stomach | stomach |
14 | chr6:11482800-11483200 | Enhancers | Colon Smooth Muscle | Colon |
15 | chr6:11483000-11485000 | Weak transcription | Fetal Stomach | stomach |
16 | chr6:11483400-11483800 | Enhancers | Lung | lung |